FindTrial
Sign In

Biomarker study and quality of life evaluation of children with allergic rhinitis and evaluation of curative effect of BiMinTongQiao Decoction in treating allergic rhinitis

Biomarker study and quality of life evaluation of children with allergic rhinitis and evaluation of curative effect of BiMinTongQiao Decoction in treating allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038664
Enrollment
Unknown
Registered
2020-09-28
Start date
2020-10-10
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Experimental group:Bimintongqiao Decoction
Control group:Biminheji (II)

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of Western medicine for allergic rhinitis and the syndrome differentiation standard of TCM for latent heat of lung meridian of rhinocercosis; 2. Patients aged from 2 to 14 years old have no gender limitation; 3. Informed consent, volunteer patients. The process of obtaining informed consent should comply with GCP.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the ingredients of the traditional Chinese medicine; 2. Children with severe complications, such as bronchial asthma attack, severe nasal polyps affecting breathing, obvious deviation of nasal septum, and children with sleep apnea syndrome requiring surgical treatment.

Design outcomes

Primary

MeasureTime frame
Allergen Testing;—

Countries

China

Contacts

Public ContactZhao Xia

Jiangsu Provincial Hospital of traditional Chinese Medicine

zhaoxiahy@njucm.edu.cn+86 13915994006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026